AXNX News and Press, Axonics Modulation Technologies Inc. From 03/22/24

Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt Axonics’ merger agreement with Boston Scientific Corporation (NYSE: BSX). According to preliminary voting results from the special meeting of stockholders held earlier today, a majority of the shares of ...

Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on two Medtronic patents that Axonics is contesting. The PTAB issued its decision with respect to Patent Nos. 8,626,314 (“the ...

2024-03-21 15:39:25 ET More on Medtronic, Axonics Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth Medtronic: Its Recent Beat Proves That It Continues To Be A Rock Boston Scientific pulls, refiles HSR notification for Axonics...

2024-03-15 15:16:36 ET More on the markets Fairlead Strategies founder: This year is the year of the long-term turnarounds Inflation Is Not Running Hot S&P 500: Stay Invested, Cut Risk, And Be Ready To Buy The Dips The next Nvidia? Goldman Sachs spotlight...

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that the Axonics R20™ rechargeable sacral neuromodulation (SNM) system has received CE Mark approval. ...

2024-03-10 18:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-08 10:34:38 ET More on Axonics Modulation Technologies Axonics ticks higher as Boston Scientific reiterates close in 1H24 Medtronic accuses Axonics of patent infringement, files ITC complaint Seeking Alpha’s Quant Rating on Axonics Modulation Technolog...

2024-03-06 14:15:48 ET More on Axonics Modulation Technologies, Boston Scientific, etc. Boston Scientific Corporation (BSX) Q4 2023 Earnings Call Transcript Boston Scientific: Portfolio Updates Driving Top-Line Growth Boston Scientific: Continued M&A Drives More ...

Axonics, Inc. (Nasdaq: AXNX) today announced that it has received notice that Medtronic has filed a complaint with the U.S. International Trade Commission (ITC), along with a parallel action in U.S. District Court for the District of Delaware. The complaint alleges that Axonics infringes two Medt...

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three months and fiscal year ended December 31, 2023. “The continued stro...